These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29017379)

  • 1. HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
    Negrini S; Becquemont L
    Pharmacogenomics; 2017 Oct; 18(15):1441-1457. PubMed ID: 29017379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and pharmacogenetics of drug hypersensitivity.
    Pavlos R; Mallal S; Phillips E
    Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic information derived from analysis of HLA alleles.
    Gatanaga H; Honda H; Oka S
    Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions.
    Schutte RJ; Sun Y; Li D; Zhang F; Ostrov DA
    Clin Lab Med; 2018 Dec; 38(4):669-677. PubMed ID: 30420060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA Association with Drug-Induced Adverse Reactions.
    Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
    J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
    Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of allopurinol--making an old drug safer.
    Lam MP; Yeung CK; Cheung BM
    J Clin Pharmacol; 2013 Jul; 53(7):675-9. PubMed ID: 23381951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside].
    Porębski G; Dyga W; Stobiecki M; Czarnobilska E
    Przegl Lek; 2015; 72(12):779-82. PubMed ID: 27024960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
    Jarjour S; Barrette M; Normand V; Rouleau JL; Dubé MP; de Denus S
    Pharmacogenomics; 2015; 16(7):755-67. PubMed ID: 25965122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls.
    Daly AK
    Curr Drug Metab; 2014 Feb; 15(2):196-201. PubMed ID: 24694233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving drug safety by locating genetic markers for hypersensitivity reactions.
    Ronaldson KJ; McNeil JJ
    Med J Aust; 2009 Jun; 190(11):641-3. PubMed ID: 19485844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.